Medtronic (MDT)
Technical, fundamental, and sentiment analysis with recent related videos.
MDT rates Bullish overall. The fundamental read is bullish: the company passes 7 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.99); revenue is growing about 5.2% per year; net income is growing about 9.2% per year. The technical picture is bullish: price is 9.8% above the 200-day moving average; 4.9% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 72/100), based on 5 news articles from recent coverage.
Revenue 3-year avg +5.2%. Net income 3-year avg +9.2%.
Price vs 20DMA +5.2%. RSI 60.13. Bollinger state: Inside Bands.
Composite score 72/100 from the AI judge, based on 5 news items, 0 television segments, and 0 videos.
Latest Market Read
Medtronic’s badges line up bullish. Fundamentals are Bullish driven by three-year averages, revenue averaged 5.2 percent per year and net income averaged 9.2 percent per year, with net income weighted more heavily so the Fundamental badge clears Bullish. Technical is Bullish: price sits 5.2 percent above the 20-day moving average, the Relative Strength Index (RSI), a momentum reading, is 60.1, and the stock trades inside the Bollinger Bands. Sentiment is Bullish with a 72 composite score. All three produce an Overall Bullish rating.
Recent news: Coverage from the Global Database of Events, Language, and Tone (GDELT) and Internet Archive TV coverage highlights strong real-world registry results for the Sphere-9 ablation catheter and PulseSelect pulsed-field ablation, citing high acute success and low major complications in more than 2,200 AF and 46 VT patients. Reporters also covered Medtronic’s rollout of new cardiac devices and digital tools and noted a 51.6% three-year share gain to about $95.41, while some pieces raised valuation questions and flagged shifts toward leadless and MRI-compatible pacemakers. Recent videos featured the CEO discussing a Q1 beat and stock-mover coverage noting share interest.